Received Jan 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | No batch number | — |
Cellulitis on her leg; Tiredness; Diarrhea; Hair thinning; Allergy to Pneumovax, Comirnaty, Flucelvax; This spontaneous case, initially received on 29-Dec-2025, was reported by a health professional and concerns an elderly female patient. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for Indication not reported., Dose regimen: Not reported, Route of administration: Not reported, Anatomical location: Not reported, Lot number: No batch number available, and would be requested upon follow-up. Non-company suspect drugs: Comirnaty (Tozinameran), for Indication not reported., Dose regimen: Not reported, Route of administration: Not reported, Anatomical location: Not reported, Lot number: Not reported Ibrance (Palbociclib), Indication: MALIGNANT NEOPLASM UPPER-INNER QUAD. Pneumovax (Pneumococcal vaccine polysacch 23v), Indication not reported., Dose regimen: Not reported, Route of administration: Not reported, Anatomical location: Not reported, Lot number: Not reported Adverse reactions/events and outcomes: On 18-Dec-2025, the patient experienced Cellulitis on her leg (outcome: Unknown), Tiredness (outcome: Unknown), Diarrhea (outcome: Unknown), Hair thinning (outcome: Unknown), Allergy to Pneumovax, Comirnaty, Flucelvax (outcome: Unknown). Reported had cellulitis on her leg, tiredness, occasional diarrhea and hair thinning. First ship date: 18-Sep-2025 Awareness Date : 18-Dec-2025 Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The primary reporters (nurse and patient) did not provide a seriousness or causality assessment for the events.; Reporter's Comments: Due to the spontaneous nature of the case, the events are considered related for reporting purposes
Ibrance